Genocea Biosciences Hires Chip Clark as Chief Business Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, a vaccine discovery and development company pioneering a new class of T cell based vaccines, today announced the appointment of Chip Clark to the position of chief business officer. Mr. Clark joins Genocea with 20 years of biotechnology and pharmaceutical experience with a focus on commercial, business development and venture capital financing.

Back to news